Lurbinectedin (Pm01183) Efficacy In Platinum-Resistant/Refractory Ovarian Cancer (Prroc) Patients Correlates With Drug Exposure Using Pharmacokinetic/Pharmacodynamic (Pk/Pd) Modelling

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER(2015)

引用 0|浏览20
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要